Evidence map›Paper›PMID 36267326›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2022

Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study.

Komal Malik, Susana Diaz-Coto, Maria de la Asunción Villaverde, Pablo Martinez-Camblor, Annie Navarro-Rolon, Francisco Pujalte, Alejandro De la Sierra, Pere Almagro

Abstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Komal MalikInternal Medicine Service, University Hospital Mútua de Terrassa, University of Barcelona, Barcelona, Spain.
Susana Diaz-CotoEpidemiology Department, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
Maria de la Asunción VillaverdeInternal Medicine Service, University Hospital Mútua de Terrassa, University of Barcelona, Barcelona, Spain.
Pablo Martinez-CamblorDepartment of Anesthesiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Annie Navarro-RolonPneumology Service, University Hospital Mútua de Terrassa, University of Barcelona, Barcelona, Spain.
Francisco PujalteImmunology Department, Catlab Laboratory, Barcelona, Spain.
Alejandro De la SierraInternal Medicine Service, University Hospital Mútua de Terrassa, University of Barcelona, Barcelona, Spain.
Pere AlmagroInternal Medicine Service, University Hospital Mútua de Terrassa, University of Barcelona, Barcelona, Spain.ORCID 0000-0002-8476-4942

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Several mechanisms have been proposed to explain why chronic obstructive pulmonary disease (COPD) impairs the prognosis of coronary events. We aimed to explore COPD variables related to a worse prognosis in patients undergoing percutaneous coronary intervention (PCI). Methods: Patients with an acute coronary event treated by PCI were prospectively included. One month after discharge, clinical characteristics, comorbidities measured with the Charlson index, and prognostic coronary scales (logistic EuroSCORE; GRACE 2.0) were collected. Post-bronchodilator spirometry, arterial stiffness, and serum inflammatory and myocardial biomarkers were measured. Lung plasmatic biomarkers (Surfactant protein D, desmosine, and Clara cell secretory protein-16) were determined with ELISA. COPD was defined by the fixed ratio (FEV1/FVC <70%). Spirometric values were also analyzed as continuous variables using adjusted and non-adjusted ANCOVA analysis. Finally, we evaluated the presence of a respiratory pattern defined by non-stratified spirometric values and pulmonary biomarkers. Results: A total of 164 patients with a mean age of 65 (±10) years (79% males) were included. COPD was diagnosed in 56 (34%) patients (68% previously undiagnosed). COPD patients had a longer smoking history, higher scores on the EuroSCORE (p < 0.0001) and GRACE 2.0 (p < 0.001) scales, and more comorbidities (p = 0.006). Arterial stiffness determined by pulse wave velocity was increased in COPD patients (7.35 m/s vs 6.60 m/s; p = 0.006). Serum values of high sensitive T troponin (p = 0.007) and surfactant protein D (p = 0.003) were also higher in COPD patients. FEV1% remained significantly associated with arterial stiffness and surfactant protein D in the adjusted ANCOVA analysis. In the cluster exploration, 53% of the patients had a respiratory pattern. Conclusion: COPD affects one-third of patients with an acute coronary event and frequently remains undiagnosed. Several mechanisms, including arterial stiffness and SPD, were increased in COPD patients. Their relationship with the prognosis should be confirmed with longitudinal follow-up of the cohort.

Indexed as

Percutaneous Coronary InterventionPulmonary Disease, Chronic ObstructivePulmonary Surfactant-Associated Protein DVascular StiffnessAgedBiomarkersBronchodilator AgentsDesmosineFemaleHumansMaleMiddle AgedPulse Wave AnalysisTroponinUteroglobinBiomarkersBronchodilator AgentsDesmosinePulmonary Surfactant-Associated Protein DTroponinUteroglobinacute coronary eventarterial stiffnesschronic obstructive pulmonary diseaseischaemic heart diseasepercutaneous coronary interventionsurfactant protein D

Identifiers

PMID36267326
PMCPMC9578359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.